CRIS FY 2017 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M+31.5% YoY

Gross Profit

$9M95.0% margin

Operating Income

-$50M-502.7% margin

Net Income

-$53M-538.7% margin

EPS (Diluted)

$-35.75

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$49M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$74M

Total Liabilities

$50M

Stockholders' Equity

$24M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$8M	+31.5%
Gross Profit	$9M	$7M	+31.9%
Operating Income	-$50M	-$58M	+14.3%
Net Income	-$53M	-$60M	+11.7%